MG
ALBO

Michael Gelband’s Albireo Pharma Inc ALBO Stock Holding History

Michael Gelband’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-35,874
Closed -$695K – 2300
2022
Q3 		$695K Sell
35,874
-17,031
-32% -$352K 0.01% 1253
2022
Q2 		$1.05M Buy
+52,905
New +$1.4M 0.01% 1060
2022
Q1 		– Sell
-12,547
Closed -$292K – 2820
2021
Q4 		$292K Buy
+12,547
New +$334K ﹤0.01% 1670
2021
Q3 		– Sell
-6,534
Closed -$230K – 2844
2021
Q2 		$230K Buy
+6,534
New +$212K ﹤0.01% 1903
2020
Q4 		– Sell
-12,370
Closed -$413K – 2511
2020
Q3 		$413K Buy
+12,370
New +$360K 0.01% 1118

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Michael Gelband's ALBO Position: Q4 2022 in Review

Michael Gelband sold out of Albireo Pharma Inc (ALBO) in Q4 2022, closing a stake of 35,874 shares — an estimated $695K sold.

Michael Gelband first reported a position in ALBO in Q3 2020 and held it in 5 quarters. The position peaked at $1.05M in Q2 2022. 96 funds tracked by Wall St. Rank hold ALBO as of Q4 2022.

  • Michael Gelband reported no remaining Albireo Pharma Inc position as of Q4 2022 after selling out during the quarter.
  • Michael Gelband sold 35,874 Albireo Pharma Inc shares in Q4 2022, an estimated $695K.
  • Michael Gelband first reported a position in Albireo Pharma Inc in Q3 2020 and held it in 5 quarters.
  • Michael Gelband's Albireo Pharma Inc position peaked at $1.05M in Q2 2022.
  • 96 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2022.

Based on ExodusPoint Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.